You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2025

Drug Price Trends for NDC 61314-0665


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 61314-0665

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
APRACLONIDINE HCL 0.5%SOLN,OPH Sandoz, Inc. 61314-0665-10 10ML 60.40 6.04000 2024-01-01 - 2028-08-14 FSS
APRACLONIDINE HCL 0.5%SOLN,OPH Sandoz, Inc. 61314-0665-05 5ML 20.66 4.13200 2023-08-15 - 2028-08-14 FSS
APRACLONIDINE HCL 0.5%SOLN,OPH Sandoz, Inc. 61314-0665-05 5ML 26.72 5.34400 2024-01-01 - 2028-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 61314-0665

Last updated: January 4, 2025

Understanding the NDC System

To analyze the market and price projections for a specific drug, it is crucial to understand the National Drug Code (NDC) system. The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs. It is used to identify and report drugs manufactured, prepared, propagated, compounded, or processed for sale in the U.S.[1].

Drug Identification: NDC 61314-0665

The NDC 61314-0665 corresponds to a specific drug product. However, the provided sources do not directly mention this NDC. To analyze this drug, we need to identify its generic name, brand name, dosage form, and other relevant details. For example, another NDC from the same manufacturer (61314-0312) corresponds to Zarxio, a filgrastim-sndz injection solution[5].

Market Trends in the Pharmaceutical Industry

Pricing and Access Challenges

The pharmaceutical industry is facing significant challenges related to drug pricing and access. C-suite executives in the life sciences sector identify pricing and access to drugs as a major issue, with nearly half expecting it to significantly impact their strategies in 2025[3].

Price Increases and Negotiations

Historically, many prescription drugs have seen substantial price increases. For instance, nine out of ten drugs selected for the Medicare Drug Price Negotiation Program had list price increases ranging from 20% to 55% between 2018 and 2023[2]. However, negotiations under programs like Medicare Part D have resulted in significant discounts, ranging from 38% to 79% compared to list prices[2].

Impact of Generic and Biosimilar Drugs

The market is also influenced by the presence of generic and biosimilar drugs. Competition from these alternatives is a top trend, with 37% of life sciences executives viewing it as a significant factor. The patent cliff, with over $300 billion in sales at risk through 2030 due to expiring patents, further complicates the pricing landscape[3].

Price Projections

Net Price Growth

Despite publicized high price increases, the average net price growth of marketed drugs has been relatively stable in recent years. The average net price growth slowed to 2.8% in 2015 from 9.5% over the previous five years, largely due to greater price concessions offered by manufacturers[4].

Manufacturer Commitments

Some manufacturers, like Novo Nordisk and Allergan, have committed to limiting annual price increases to single digits. This trend is likely to continue, driven by increasing price transparency and higher patient out-of-pocket burdens[4].

Specific Drug Analysis

Lack of Direct Data

Since the specific NDC 61314-0665 is not mentioned in the provided sources, we cannot draw direct conclusions about its price projections. However, we can infer from similar drugs and market trends.

Analogous Drug Example

Using Zarxio (NDC 61314-0312) as an example, we see that it is a biosimilar product, which often faces different pricing dynamics compared to branded drugs. Biosimilars typically enter the market at a lower price point than their branded counterparts, which can lead to competitive pricing pressures[5].

Regulatory and Market Factors

FDA Regulations

The FDA's National Drug Code Directory and reporting requirements play a crucial role in tracking and regulating drug prices. Compounded drug products, including those from outsourcing facilities, are also subject to specific regulations and reporting requirements[1].

Market Access and Affordability

High prescription drug prices continue to create affordability challenges for patients, healthcare payers, and taxpayers. Initiatives like the Medicare Drug Price Negotiation Program aim to make prescription drugs more affordable by negotiating lower prices[2].

Key Takeaways

  • Pricing Trends: The pharmaceutical industry is experiencing stable to slow net price growth, with significant discounts resulting from negotiations.
  • Generic and Biosimilar Impact: Competition from generic and biosimilar drugs is a major factor influencing pricing.
  • Regulatory Environment: FDA regulations and reporting requirements are critical in managing drug prices and market access.
  • Affordability Initiatives: Programs like Medicare Part D negotiations are aimed at making drugs more affordable.
  • Manufacturer Commitments: Some manufacturers are committing to single-digit annual price increases.

FAQs

What is the National Drug Code (NDC) and its significance?

The National Drug Code (NDC) is a unique three-segment number used by the FDA to identify and report drugs manufactured, prepared, propagated, compounded, or processed for sale in the U.S. It serves as the FDA’s identifier for drugs.

How do generic and biosimilar drugs impact the pharmaceutical market?

Generic and biosimilar drugs introduce competition that can lower prices and increase market access. They often enter the market at a lower price point than branded drugs, leading to competitive pricing pressures.

What is the Medicare Drug Price Negotiation Program, and how does it affect drug prices?

The Medicare Drug Price Negotiation Program negotiates lower prices for prescription drugs under Medicare Part D. This program has resulted in significant discounts, ranging from 38% to 79% compared to list prices.

How do FDA regulations influence drug pricing and market access?

FDA regulations, including the National Drug Code Directory and reporting requirements, help track and regulate drug prices. These regulations ensure transparency and compliance, which can impact pricing and market access.

What are the current trends in pharmaceutical pricing, and how do they affect affordability?

Current trends include stable to slow net price growth, significant discounts from negotiations, and commitments from manufacturers to limit annual price increases. These trends aim to make prescription drugs more affordable for patients and healthcare payers.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Medicare Drug Price Negotiation Program - ASPE, HHS.gov
  3. 2025 Life Sciences Executive Outlook - Deloitte Insights
  4. Pricing and Market Access Outlook - IQVIA
  5. Zarxio - CanMED: NDC - SEER Cancer

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.